Kirn David — SEC insider filings

SEC reporting owner CIK 1834021. 23 insider filings on record with FilingPulse; latest filed 2026-10-07.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2021-03-10 to 2026-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
4D Molecular Therapeutics, Inc. (FDMT)See Remarks, Director23—30 legs · 766,700 sh · $13,280,08116

Insider filings — Kirn David

FiledFormIssuerReported transactionsSource
2026-10-0744D Molecular Therapeutics, Inc. (FDMT)Sale (S): 58,061 @ $12.92 · Sale (S): 272 @ $13.61EDGAR
2026-09-1644D Molecular Therapeutics, Inc. (FDMT)Sale (S): 58,333 @ $13.90EDGAR
2026-08-2144D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 50,000 @ $4.14 · Sale (S): 43,149 @ $15.36 · Sale (S): 25,927 @ $16.42 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2026-08-0544D Molecular Therapeutics, Inc. (FDMT)Sale (S): 26,842 @ $10.23EDGAR
2026-08-0444D Molecular Therapeutics, Inc. (FDMT)Sale (S): 12,415 @ $10.05EDGAR
2026-07-1444D Molecular Therapeutics, Inc. (FDMT)Sale (S): 42,608 @ $12.87 · Sale (S): 15,283 @ $12.01 · Sale (S): 442 @ $12.84EDGAR
2026-06-2344D Molecular Therapeutics, Inc. (FDMT)Sale (S): 114,746 @ $10.47EDGAR
2026-06-0244D Molecular Therapeutics, Inc. (FDMT)Sale (S): 1,922 @ $10.02EDGAR
2026-03-2744D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 750,000 (derivative) @ $0EDGAR
2025-03-1044D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 267,500 (derivative) @ $0EDGAR
2024-07-1244D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 11,653 @ $14.42 · Option exercise (M): 1,270 @ $15.78 · Sale (S): 12,923 @ $22.49 · Option exercise (M): 11,653 (derivative) @ $0 · Option exercise (M): 1,270 (derivative) @ $0EDGAR
2024-06-2644D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 12,930 @ $14.42 · Sale (S): 12,930 @ $23.10 · Option exercise (M): 12,930 (derivative) @ $0EDGAR
2024-02-1244D Molecular Therapeutics, Inc. (FDMT)Sale (S): 92,001 @ $27.13EDGAR
2024-01-2544D Molecular Therapeutics, Inc. (FDMT)Sale (S): 5,696 @ $18.41EDGAR
2024-01-0844D Molecular Therapeutics, Inc. (FDMT)Sale (S): 28,632 @ $17.27 · Sale (S): 4,702 @ $18.13 · Sale (S): 40,732 @ $20.31 · Sale (S): 28,104 @ $19.56 · Sale (S): 133 @ $20.11EDGAR
2023-12-1344D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 590,000 (derivative) @ $0EDGAR
2023-05-0444D Molecular Therapeutics, Inc. (FDMT)Gift (G): 600,000 @ $0 · Gift (G): 600,000 @ $0EDGAR
2023-02-2344D Molecular Therapeutics, Inc. (FDMT)Sale (S): 17,090 @ $20.93 · Sale (S): 907 @ $21.49 · Sale (S): 16,449 @ $20.22EDGAR
2023-02-1444D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 222,000 (derivative) @ $0EDGAR
2023-01-2344D Molecular Therapeutics, Inc. (FDMT)Sale (S): 10,899 @ $20.03 · Sale (S): 8,625 @ $20.19EDGAR
2022-12-1944D Molecular Therapeutics, Inc. (FDMT)Sale (S): 31,433 @ $23.56 · Sale (S): 1,500 @ $24.13 · Sale (S): 27,595 @ $22.66 · Sale (S): 26,349 @ $23.39EDGAR
2022-02-0344D Molecular Therapeutics Inc. (FDMT)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2021-03-1044D Molecular Therapeutics Inc. (FDMT)Grant/award (A): 150,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1834021 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs